健康年轻人粪便中的二氧化钛与粪便中的α-1 抗胰蛋白酶和钙粘蛋白呈正相关关系

IF 4.7 3区 环境科学与生态学 Q2 ENVIRONMENTAL SCIENCES
Christianto Putra, Dhimiter Bello, Shannon L. Kelleher, Katherine L. Tucker, Kelsey M. Mangano
{"title":"健康年轻人粪便中的二氧化钛与粪便中的α-1 抗胰蛋白酶和钙粘蛋白呈正相关关系","authors":"Christianto Putra,&nbsp;Dhimiter Bello,&nbsp;Shannon L. Kelleher,&nbsp;Katherine L. Tucker,&nbsp;Kelsey M. Mangano","doi":"10.1016/j.impact.2024.100498","DOIUrl":null,"url":null,"abstract":"<div><p>Titanium dioxide (TiO2/E171) is used widely in foods, primarily as a food additive. Animal models have shown that chronic TiO<sub>2</sub> exposure may disturb homeostasis of the gastrointestinal tract by increasing gut permeability, inducing gut inflammation, and increasing the likelihood of microbial infection. Adults have a wide range of ingested TiO<sub>2</sub>,which span two to three orders of magnitude, with a small portion of individuals consuming near gram quantities of TiO2/day. However, research on the health effects of chronic ingestion of TiO2/E171 in humans is limited. We hypothesized that regularly ingested TiO2/E171 is associated with increased gut inflammation and gut permeability in healthy adults. We tested this hypothesis in a cross-sectional design by measuring clinically established stool markers of gut inflammation (calprotectin, lactoferrin) and gut permeability (alpha-1 antitrypsin; A1AT) in 35 healthy adults, and comparing these markers between relatively high and low TiO2 exposure groups. Participants were stratified by TiO2 stool content (high dry stool TiO2 content: 0.95–9.92 μg/mg, <em>n</em> = 20; low content: 0.01–0.04 μg/mg; <em>n</em> = 15). Differences in gut health markers were tested between high and low exposure groups by independent samples <em>t</em>-test or Mann-Whitney <em>U</em> test. Multivariable linear regression was used to assess the association between TiO2 in dry stool and measured stool alpha-1 antitrypsin (A1AT). Participants in the high stool TiO2 group had greater stool A1AT (42.7 ± 21.6 mg/dL; median: 38.3; range: 1.0–49.2 mg/dL), compared to the low TiO2 group (22.8 ± 13.6 mg/dL; median: 20.9; range: 8.7–93.0 mg/dL), <em>P</em> = 0.003. There was also greater stool calprotectin in the high TiO<sub>2</sub> group (51.4 ± 48.6 μg/g; median 29.2 μg/g; range: 15.3–199.0 μg/g) than in the low group (47.5 ± 63.3 μg/g; median 18.8 μg/g; range: 1.6–198.1 μg/g), <em>P</em> = 0.04. No clear difference was observed for lactoferrin (high TiO2 group 1.6 ± 2.1 μg/g; median: 0.68 μg/g; range: 0.01–7.7 μg/g, low TiO2 group: 1.3 ± 2.6 μg/g; median: 0.2; range: 0.01–7.6 μg/g) (<em>P</em> = 0.15). A1AT concentration was positively associated with stool TiO2, after adjusting for confounders (β ± SE: 19.6 ± 7.2; <em>P</em> = 0.01) R<sup>2</sup> = 0.38). Community dwelling, healthy adults with the highest TiO2 stool content had higher stool A1AT and calprotectin, compared to those with the lowest TiO<sub>2</sub> stool content. Ongoing research is needed to validate these observations in larger groups, and to determine the long-term effects of ingested TiO<sub>2</sub> on human gut health, using these and additional health endpoints.</p></div>","PeriodicalId":18786,"journal":{"name":"NanoImpact","volume":"33 ","pages":"Article 100498"},"PeriodicalIF":4.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stool titanium dioxide is positively associated with stool alpha-1 antitrypsin and calprotectin in young healthy adults\",\"authors\":\"Christianto Putra,&nbsp;Dhimiter Bello,&nbsp;Shannon L. Kelleher,&nbsp;Katherine L. Tucker,&nbsp;Kelsey M. Mangano\",\"doi\":\"10.1016/j.impact.2024.100498\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Titanium dioxide (TiO2/E171) is used widely in foods, primarily as a food additive. Animal models have shown that chronic TiO<sub>2</sub> exposure may disturb homeostasis of the gastrointestinal tract by increasing gut permeability, inducing gut inflammation, and increasing the likelihood of microbial infection. Adults have a wide range of ingested TiO<sub>2</sub>,which span two to three orders of magnitude, with a small portion of individuals consuming near gram quantities of TiO2/day. However, research on the health effects of chronic ingestion of TiO2/E171 in humans is limited. We hypothesized that regularly ingested TiO2/E171 is associated with increased gut inflammation and gut permeability in healthy adults. We tested this hypothesis in a cross-sectional design by measuring clinically established stool markers of gut inflammation (calprotectin, lactoferrin) and gut permeability (alpha-1 antitrypsin; A1AT) in 35 healthy adults, and comparing these markers between relatively high and low TiO2 exposure groups. Participants were stratified by TiO2 stool content (high dry stool TiO2 content: 0.95–9.92 μg/mg, <em>n</em> = 20; low content: 0.01–0.04 μg/mg; <em>n</em> = 15). Differences in gut health markers were tested between high and low exposure groups by independent samples <em>t</em>-test or Mann-Whitney <em>U</em> test. Multivariable linear regression was used to assess the association between TiO2 in dry stool and measured stool alpha-1 antitrypsin (A1AT). Participants in the high stool TiO2 group had greater stool A1AT (42.7 ± 21.6 mg/dL; median: 38.3; range: 1.0–49.2 mg/dL), compared to the low TiO2 group (22.8 ± 13.6 mg/dL; median: 20.9; range: 8.7–93.0 mg/dL), <em>P</em> = 0.003. There was also greater stool calprotectin in the high TiO<sub>2</sub> group (51.4 ± 48.6 μg/g; median 29.2 μg/g; range: 15.3–199.0 μg/g) than in the low group (47.5 ± 63.3 μg/g; median 18.8 μg/g; range: 1.6–198.1 μg/g), <em>P</em> = 0.04. No clear difference was observed for lactoferrin (high TiO2 group 1.6 ± 2.1 μg/g; median: 0.68 μg/g; range: 0.01–7.7 μg/g, low TiO2 group: 1.3 ± 2.6 μg/g; median: 0.2; range: 0.01–7.6 μg/g) (<em>P</em> = 0.15). A1AT concentration was positively associated with stool TiO2, after adjusting for confounders (β ± SE: 19.6 ± 7.2; <em>P</em> = 0.01) R<sup>2</sup> = 0.38). Community dwelling, healthy adults with the highest TiO2 stool content had higher stool A1AT and calprotectin, compared to those with the lowest TiO<sub>2</sub> stool content. Ongoing research is needed to validate these observations in larger groups, and to determine the long-term effects of ingested TiO<sub>2</sub> on human gut health, using these and additional health endpoints.</p></div>\",\"PeriodicalId\":18786,\"journal\":{\"name\":\"NanoImpact\",\"volume\":\"33 \",\"pages\":\"Article 100498\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NanoImpact\",\"FirstCategoryId\":\"93\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452074824000089\",\"RegionNum\":3,\"RegionCategory\":\"环境科学与生态学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENVIRONMENTAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NanoImpact","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452074824000089","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

二氧化钛(TiO2/E171)被广泛应用于食品中,主要用作食品添加剂。动物模型显示,长期接触二氧化钛可能会增加肠道渗透性、诱发肠道炎症和增加微生物感染的可能性,从而扰乱胃肠道的平衡。成年人摄入的二氧化钛量范围很广,可达到两到三个数量级,一小部分人每天摄入的二氧化钛量接近一克。然而,有关长期摄入 TiO2/E171 对人体健康影响的研究十分有限。我们假设,健康成年人定期摄入 TiO2/E171 与肠道炎症和肠道渗透性增加有关。我们在横断面设计中测试了这一假设,测量了35名健康成年人的临床确定的肠道炎症粪便标志物(钙蛋白、乳铁蛋白)和肠道渗透性标志物(α-1抗胰蛋白酶;A1AT),并在相对较高和较低的二氧化钛暴露组之间比较了这些标志物。根据粪便中 TiO2 的含量对参与者进行了分层(高干粪便 TiO2 含量:0.95-9.92 μg/L):0.95-9.92微克/毫克,n = 20;低含量:0.01-0.04微克/毫克,n = 20:0.01-0.04 μg/mg; n = 15)。通过独立样本 t 检验或 Mann-Whitney U 检验检测了高含量组和低含量组之间肠道健康指标的差异。多变量线性回归用于评估干燥粪便中的二氧化钛与测量的粪便α-1抗胰蛋白酶(A1AT)之间的关系。与低 TiO2 组(22.8 ± 13.6 mg/dL;中位数:20.9;范围:8.7-93.0 mg/dL)相比,高粪便 TiO2 组参与者的粪便 A1AT 较高(42.7 ± 21.6 mg/dL;中位数:38.3;范围:1.0-49.2 mg/dL),P = 0.003。高 TiO2 组的粪便钙蛋白(51.4 ± 48.6 μg/g;中位数:29.2 μg/g;范围:15.3-199.0 μg/g)也高于低 TiO2 组(47.5 ± 63.3 μg/g;中位数:18.8 μg/g;范围:1.6-198.1 μg/g),P = 0.04。乳铁蛋白没有明显差异(高 TiO2 组 1.6 ± 2.1 μg/g;中位数:0.68 μg/g;范围:1.6 ± 2.1 μg/g),P = 0.04:0.68 μg/g; range:0.01-7.7 μg/g,低 TiO2 组:1.3±2.6微克/克;中位数:0.2;范围:0.01-7.7微克/克0.2;范围: 0.01-7.6 μg/g0.01-7.6 μg/g)(P = 0.15)。调整混杂因素后,A1AT 浓度与粪便 TiO2 呈正相关(β ± SE:19.6 ± 7.2;P = 0.01),R2 = 0.38)。与大便中 TiO2 含量最低的人群相比,大便中 TiO2 含量最高的社区健康成年人的大便 A1AT 和 calprotectin 更高。需要继续进行研究,以便在更大的群体中验证这些观察结果,并利用这些和其他健康终点来确定摄入的二氧化钛对人体肠道健康的长期影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Stool titanium dioxide is positively associated with stool alpha-1 antitrypsin and calprotectin in young healthy adults

Titanium dioxide (TiO2/E171) is used widely in foods, primarily as a food additive. Animal models have shown that chronic TiO2 exposure may disturb homeostasis of the gastrointestinal tract by increasing gut permeability, inducing gut inflammation, and increasing the likelihood of microbial infection. Adults have a wide range of ingested TiO2,which span two to three orders of magnitude, with a small portion of individuals consuming near gram quantities of TiO2/day. However, research on the health effects of chronic ingestion of TiO2/E171 in humans is limited. We hypothesized that regularly ingested TiO2/E171 is associated with increased gut inflammation and gut permeability in healthy adults. We tested this hypothesis in a cross-sectional design by measuring clinically established stool markers of gut inflammation (calprotectin, lactoferrin) and gut permeability (alpha-1 antitrypsin; A1AT) in 35 healthy adults, and comparing these markers between relatively high and low TiO2 exposure groups. Participants were stratified by TiO2 stool content (high dry stool TiO2 content: 0.95–9.92 μg/mg, n = 20; low content: 0.01–0.04 μg/mg; n = 15). Differences in gut health markers were tested between high and low exposure groups by independent samples t-test or Mann-Whitney U test. Multivariable linear regression was used to assess the association between TiO2 in dry stool and measured stool alpha-1 antitrypsin (A1AT). Participants in the high stool TiO2 group had greater stool A1AT (42.7 ± 21.6 mg/dL; median: 38.3; range: 1.0–49.2 mg/dL), compared to the low TiO2 group (22.8 ± 13.6 mg/dL; median: 20.9; range: 8.7–93.0 mg/dL), P = 0.003. There was also greater stool calprotectin in the high TiO2 group (51.4 ± 48.6 μg/g; median 29.2 μg/g; range: 15.3–199.0 μg/g) than in the low group (47.5 ± 63.3 μg/g; median 18.8 μg/g; range: 1.6–198.1 μg/g), P = 0.04. No clear difference was observed for lactoferrin (high TiO2 group 1.6 ± 2.1 μg/g; median: 0.68 μg/g; range: 0.01–7.7 μg/g, low TiO2 group: 1.3 ± 2.6 μg/g; median: 0.2; range: 0.01–7.6 μg/g) (P = 0.15). A1AT concentration was positively associated with stool TiO2, after adjusting for confounders (β ± SE: 19.6 ± 7.2; P = 0.01) R2 = 0.38). Community dwelling, healthy adults with the highest TiO2 stool content had higher stool A1AT and calprotectin, compared to those with the lowest TiO2 stool content. Ongoing research is needed to validate these observations in larger groups, and to determine the long-term effects of ingested TiO2 on human gut health, using these and additional health endpoints.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
NanoImpact
NanoImpact Social Sciences-Safety Research
CiteScore
11.00
自引率
6.10%
发文量
69
审稿时长
23 days
期刊介绍: NanoImpact is a multidisciplinary journal that focuses on nanosafety research and areas related to the impacts of manufactured nanomaterials on human and environmental systems and the behavior of nanomaterials in these systems.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信